Riskpilot← Back to searchSign inGet full accessRecip AB
ABActiveOrg 5566948849Pipers Väg 2 AWholesale of pharmaceutical and medical goods · NACE 4646Est. 20050 employees
Revenue 2024
SEK 0
EBITDA margin
—
-13% vs 2023
Equity ratio
7.2%
Financial strength
Net profit 2024
SEK -568K
-137% vs 2023
| Revenue | SEK 0 | — |
| EBITDA | SEK 79M | -13% |
| Net profit | SEK -568K | -137% |
| Total assets | SEK 974,5M | +6% |
| Equity | SEK 69,8M | -1% |
| Employees | 0 | — |
Legal name
Recip AB
Org number
5566948849
Legal form
Aktiebolag
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
21 december 2005
Share capital
SEK 100 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamöterna
Company purpose
Bolaget ska bedriva miljömedveten utveckling, tillverkning och försäljning av läkemedel, naturläkemedel, naturmedel, kosttillskott, medicinska hjälpmedel och därmed förenlig verksamhet.
Address
Pipers Väg 2 A
Phone
+4686301900
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | 83 039 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Staff expenses | — | — | — | — | — | — | — | — | — | — |
| EBITDA | 78 014 | 79 889 | 81 565 | 85 623 | 88 727 | 90 186 | 76 054 | 21 736 | 90 522 | 79 042 |
| Depreciation & amort. | −7 148 | −7 898 | −5 177 | −3 013 | −1 874 | −0 | −0 | −0 | −0 | −0 |
| EBIT | 70 866 | 71 991 | 76 388 | 82 610 | 86 853 | 90 186 | 76 054 | 21 736 | 90 522 | 79 042 |
| Net financials | 1 205 | 477 | 1 513 | 1 909 | −9 195 | −2 221 | −2 781 | 452 | 1 555 | −699 |
| Profit before tax | 0 | −54 | 0 | 0 | 19 576 | −2 221 | −2 782 | 452 | 1 555 | −568 |
| Tax | −0 | −0 | −0 | −0 | −4 189 | −0 | −0 | −0 | −0 | −0 |
| Net profit | 0 | −54 | 0 | 0 | 15 387 | −2 221 | −2 782 | 452 | 1 555 | −568 |
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 278 881 | 351 308 | 434 252 | 535 656 | 608 666 | 718 541 | 789 791 | 777 638 | 917 607 | 974 453 |
| Equity | 58 036 | 57 982 | 57 982 | 57 982 | 73 369 | 71 149 | 68 369 | 68 821 | 70 376 | 69 808 |
| Long-term debt | 0 | 0 | 0 | 200 | 200 | 200 | 0 | 708 771 | 847 168 | 895 032 |
| Short-term debt | 220 845 | 293 326 | 376 270 | 477 474 | 535 096 | 647 192 | 721 422 | 46 | 64 | 9 612 |
| Total debt | 220 845 | 293 326 | 376 270 | 477 674 | 535 296 | 647 392 | 721 422 | 708 817 | 847 232 | 904 644 |
EBITDA margin
7904200000.0%
This company
15.8%
Market median
+50026582178% vs market
20152024
Equity ratio
7.2%
This company
38.2%
Market median
-81% vs market
20152024
Return on equity
-0.8%
This company
18.4%
Market median
-104% vs market
20152024
Net profit margin
-56800000.0%
This company
8.1%
Market median
-701234668% vs market
20152024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20152024
Debt / equity
12.96×
This company
0.62×
Market median
-1990% vs market
20152024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Bolagsverket / SCB · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Bolagsverket / SCB · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Bolagsverket / SCB · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Bolagsverket / SCB · Period 2015-01-01 – 2015-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
AP Chief Auditor | Chief Auditor | 2021 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 2023 | — | — | |
| Board of Directors | 2024 | — | — | |
| Board of Directors | 2021 | — | — | |
| Board of Directors | 2021 | — | — | |
| Board of Directors | 2024 | — | — | |
| Board of Directors | 2021 | — | — | |
| Deputy Board Member | 2021 | — | — | |
| Chairman | 2021 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Ipex AB | Company | 100.0% | 100.0% | 0001 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Bgp Products AB
Recip AB Board members of Recip AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Arne Pontus Pålsson | Chief Auditor | 0 companies |
| Lars Henrik Andreas Rejnus | Chairman | 0 companies |
| Bernard Christiaan Spoelstra | Board of Directors | 0 companies |
| Caroline Rebecca Louise Dixon | Board of Directors | 0 companies |
| Jenny Friberg | Board of Directors | 0 companies |
| Jan-Christer Stefan Engryd | Board of Directors | 0 companies |
| Jose Javier Cotarelo | Board of Directors | 0 companies |
| Vidar Sie | Deputy Board Member | 0 companies |
| Luis Rodolfo Birbuet | Chairman | 0 companies |